| PROGRAM |

​DAY 1

20 November 2018

SAFETY PHARMACOLOGY

 
07:30 – 08:30         
Registration / Coffee
 
09:00 – 09:45
Development of safety pharmacology and intro to the Safety Pharmacology Society
Dr Michael Pugsley
Safety Pharmacology Society | USA
 
09:45 – 10:30
In Vivo safety pharmacology models used in early de-risking strategies, including CV, respiratory and CNS models
Dr Christophe Drieu la Rochelle
Biotrial | France
 
10:30 – 11:00
Discussion
 
11:15 – 11:45
Drug-induced effects on the respiratory system
Dr Michael Pugsley
Safety Pharmacology Society | USA
 
12:30 – 13:15
Drug-induced effects on the gastrointestinal and renal systems
Prof Brian Guth
Boehringer-Ingelheim AG | Germany
 
14:15 – 15:00
Mini-pig as test species for safety studies
Dr Andrea Greiter-Wilke
Roche | Switserland
 
15:45 – 16:30
Specialized animal models
Dr Karen Svenson
The Jackson Laboratory | USA
 
18:00 –  21:00
Cocktail Function - Botanical Gardens, North-West University
 
08:30 – 09:00
Welcome
Glaudina Loots & Prof Awie Kotze
Dept of Science and Technology, NWU | South Africa
 
11:45 – 12:30
Drug-induced effects on the cardiovascular system (focus on telemetry based CV models in non-rodents)
Mr Michael Markert
Boehringer-Ingelheim AG | Germany
 
11:00 – 11:15
Tea / Coffee
 
13:15 – 14:15
Lunch  / Talk
Career opportunities in drug development
 
15:00 – 15:45
Novel approaches and future perspective – Including CIPA
Dr Tomas Mow
Novo Nordisk | Denmark
 
16:30 – 17:00
Discussion